Mutagenesis induced by the tumor microenvironment

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 439-446

  Yuan, Jianling ^a   Glazer, Peter M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic instability; Hypoxia; pH; supF

Indexed keywords

ARTICLE; CANCER GENETICS; CARCINOGENESIS; ENVIRONMENT; HUMAN; HYPOXIA; MALIGNANT NEOPLASTIC DISEASE; MUTAGENESIS; NONHUMAN; NUTRIENT; PH; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MUTAGENESIS; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0032565578     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00042-6     Document Type: Article

References (47)

1. [1] P.C. Nowell, The clonal evolution of tumor cell populations, Science 194 (1976) 23-28.
2. [2] L.A. Loeb, Mutator phenotype may be required for multistage carcinogenesis, Cancer Res. 51 (1991) 3075-3079.
3. [3] C.E. Bronner et al., Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer, Nature 368 (1994) 258-261.
4. [4] C.C. Harris, M. Hollstein, Clinical implications of the p53 tumor-suppressor gene, New Engl. J. Med. 329 (1993) 1318-1327, [see comments].
5. [5] B. Richards, H. Zhang, G. Phear, M. Meuth, Conditional mutator phenotypes in hMSH2-deficient tumor cell lines, Science 277 (1997) 1523-1526.
6. [6] T.Y. Reynolds, S. Rockwell, P.M. Glazer, Genetic instability induced by the tumor microenvironment, Cancer Res. 56 (1996) 5754-5757.
7. [7] D. Wilkinson, J.K. Sandhu, J.W. Breneman, J.D. Tucker, H.C. Birnboim, Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro, Br. J. Cancer 72 (1995) 1234-1240.
8. [8] J.E. Moulder, S. Rockwell, Tumor hypoxia: its impact on cancer therapy, Cancer Metastasis Rev. 5 (1987) 313-341.
9. [9] S. Rockwell, Use of hypoxia-directed drugs in the therapy of solid tumors, Semin. Oncol. 19 (1992) 29-40.
10. [10] S. Rockwell, J.P.S. Knisely, Hypoxia and angiogenesis in experimental tumor models: Therapeutic implications 1, Birkhauser Verlag, Basel, 1996, in press.
11. [11] H. Kimura et al., Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma, Cancer Res. 56 (1996) 5522-5528.
12. [12] S. Rockwell, J.E. Moulder, Hypoxic fractions of human tumors xenografted into mice: a review, Int. J. Radiat. Oncol. Biol. Phys. 19 (1990) 197-202.
13. [13] F. Kallinowski et al., Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats, Cancer Res. 48 (1988) 7264-7272.
14. [14] J.L. Wike-Hooley, J. Haveman, H.S. Reinhold, The relevance of tumour pH to the treatment of malignant disease, Radiother. Oncol. 2 (1984) 343-366.
15. [15] I.F. Tannock, D. Rotin, Acid pH in tumors and its potential for therapeutic exploitation, Cancer Res. 49 (1989) 4373-4384.
16. [16] C.S. Heacock, R.M. Sutherland, Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism, Br. J. Cancer 62 (1990) 217-225.
17. [17] T.G. Graeber et al., Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status, Mol. Cell. Biol. 14 (1994) 6264-6277.
18. [18] E.O. Pettersen, N.O. Juul, O.W. Ronning, Regulation of protein metabolism of human cells during and after acute hypoxia, Cancer Res. 46 (1986) 4346-4351.
19. [19] J.M. Brown, A.J. Giaccia, Tumour hypoxia: the picture has changed in the 1990s, Int. J. Radiat. Biol. 65 (1994) 95-102.
20. [20] O. Amellem, E.O. Pettersen, Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage, Cell Prolif. 24 (1991) 127-141.
21. [21] G.C. Rice, V. Ling, R.T. Schimke, Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance, Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 9261-9264.
22. [22] H. Probst et al., Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and in vivo, Cancer Res. 48 (1988) 2053-2060.
23. [23] C.R. Welbourn et al., Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil, Br. J. Surg. 78 (1991) 651-655.
24. [24] K.C. Cheng, D.S. Cahill, H. Kasai, S. Nishimura, L.A. Loeb, 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions, J. Biol. Chem. 267 (1992) 166-172.
25. [25] D.L. Stoler, G.R. Anderson, C.A. Russo, A.M. Spina, T.A. Beerman, Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells, Cancer Res. 52 (1992) 4372-4378.
26. [26] C.A. Russo et al., An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer, Cancer Res. 55 (1995) 1122-1128.
27. [27] G.C. Rice, C. Hoy, R.T. Schimke, Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 5978-5982.
28. [28] G.C. Rice, I.J. Spiro, C.C. Ling, Detection of S-phase over-replication following chronic hypoxia using a monoclonal anti-BrdUrd, Int. J. Radiat. Oncol. Biol. Phys. 11 (1985) 1817-1822.
29. [29] S.D. Young, R.S. Marshall, R.P. Hill, Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9533-9537.
30. [30] R.T. Schimke, S.W. Sherwood, A.B. Hill, R.N. Johnston, Overreplication and recombination of DNA in higher eukaryotes: potential consequences and biological implications, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 2157-2161.
31. [31] B.A. Teicher, Hypoxia and drug resistance, Cancer Metastasis Rev. 13 (1994) 139-168.
32. [32] M. Hockel et al., Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res. 56 (1996) 4509-4515.
33. [33] D.M. Brizel et al., Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma, Cancer Res. 56 (1996) 941-943.
34. [34] C. Cuvier, A. Jang, R.P. Hill, Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L+ B) secretion, Clin. Exp. Metastasis 15 (1997) 19-25.
35. [35] P. Hahn, L.N. Kapp, W.F. Morgan, R.B. Painter, Chromosomal changes without DNA overproduction in hydroxyurea-treated mammalian cells: implications for gene amplification, Cancer Res. 46 (1986) 4607-4612.
36. [36] R.B. Painter, B.R. Young, L.N. Kapp, Absence of DNA overreplication in Chinese hamster cells incubated with inhibitors of DNA synthesis, Cancer Res. 47 (1987) 5595-5599.
37. [37] E.K. Rofstad, N.M. Johnsen, H. Lyng, Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro, Br. J. Cancer 74 (27) (1996) S136-S139.
38. [38] K.A. Eckert, T.A. Kunkel, Fidelity of DNA synthesis catalyzed by human DNA polymerase alpha and HIV-1 reverse transcriptase: effect of reaction pH, Nucleic Acids Res. 21 (1993) 5212-5220.
39. [39] K.A. Eckert, T.A. Kunkel, Effect of reaction pH on the fidelity and processivity of exonuclease-deficient Klenow polymerase, J. Biol. Chem. 268 (1993) 13462-13471.
40. [40] O.K. Schlappack, A. Zimmermann, R.P. Hill, Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells, Br. J. Cancer 64 (1991) 663-670.
41. [41] E.I. Goncharova, A. Nadas, T.G. Rossman, Serum deprivation, but not inhibition of growth per se, induces a hypermutable state in Chinese hamster G12 cells, Cancer. Res. 56 (1996) 752-756.
42. [42] M.J. Boyer, I.E. Tannock, Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions, Cancer Res. 52 (1992) 4441-4447.
43. [43] D. Rotin, B. Robinson, I.F. Tannock, Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors, Cancer Res. 46 (1986) 2821-2826.
44. [44] S. Rockwell, In vivo-in vitro tumor systems: New models for studying the response of tumors to therapy, Lab. Anim. Sci. 27 (1977) 831-851.
45. [45] T.G. Graeber et al., Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours, Nature 379 (1996) 88-91.
46. [46] R.S. Harris et al., Mismatch repair protein MutL becomes limiting during stationary-phase mutation, Genes Dev. 11 (1997) 2426-2437.
47. [47] L.A. Loeb, Transient expression of a mutator phenotype in cancer cells, Science 277 (1997) 1449-1450, [comment].